8-K/A filed September 30, 2022, 7:59 PM ET ticker BRNS CIK 0001828185

leadership confidence high sentiment neutral materiality 0.50

Vaccitech grants new CFO Gemma Brown options to acquire 334,000 shares

Barinthus Biotherapeutics plc.

Options granted on Sep 26, 2022 under the 2021 Share Award Plan.
Options vest in three equal annual installments subject to continued employment.
On death or non-misconduct termination, unvested options may vest per Board; forfeiture on misconduct.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Gemma Brown

Chief Financial Officer

BRNS · Barinthus Biotherapeutics plc.

Effective: 2022-09-20
Filed: September 30, 2022, 7:59 PM ET

the Board of Directors (the “Board”) of the Company had appointed Gemma Brown as the Company’s Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gemma Brown was appointed as Chief Financial Officer at Barinthus Biotherapeutics plc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

the Board of Directors (the “Board”) of the Company had appointed Gemma Brown as the Company’s Chief Financial Officer.

View on SEC.gov

Barinthus Biotherapeutics plc. filing history →

Source: SEC EDGAR

accession 0001104659-22-104578

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.